Referencias principales
- Ref. 1 · 2016A clinical approach to diagnosis of autoimmune encephalitisGraus F, Titulaer MJ, Balu R, et al.Lancet Neurol. 15(4):391-404Ver en PubMed
- Ref. 2 · 2021Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute managementAbboud H, Probasco JC, Irani S, et al.J Neurol Neurosurg Psychiatry. 92(7):757-768Ver en PubMed
- Ref. 3 · 2020Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patientCellucci T, Van Mater H, Graus F, et al.Neurol Neuroimmunol Neuroinflamm. 7(2):e663Ver en PubMed
- Ref. 4 · 2013Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitisTitulaer MJ, McCracken L, Gabilondo I, et al.Lancet Neurol. 12(2):157-65Ver en PubMed
- Ref. 5 · 2019An update on anti-NMDA receptor encephalitis for neurologists and psychiatristsDalmau J, Armangué T, Planagumà J, et al.Lancet Neurol. 18(11):1045-1057Ver en PubMed
- Ref. 6 · 2016Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort studyLee WJ, Lee ST, Moon J, et al.Neurotherapeutics. 13(4):824-832Ver en PubMed
- Ref. 7 · 2016Anti-LGI1 encephalitis: clinical syndrome and long-term follow-upvan Sonderen A, Thijs RD, Coenders EC, et al.Neurology. 87(14):1449-1456Ver en PubMed
- Ref. 8 · 2018Antibody-mediated encephalitisDalmau J, Graus F.N Engl J Med. 378(9):840-851Ver en PubMed
- Ref. 9 · 2021International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitisNosadini M, Thomas T, Eyre M, et al.Neurol Neuroimmunol Neuroinflamm. 8(5):e1052Ver en PubMed
Cómo se cita este sitio
Si usas información de jmvaldes.cl con fines académicos o divulgativos, sugerimos:
Valdés JM. Encefalitis autoinmune: información para pacientes y familias. jmvaldes.cl. Consultado en mayo de 2026.